Article info
Scientific Abstracts
Poster Presentations
Posters
Epidemiology, health services and outcome research
FRI0405 Simultaneously forecasting burden of illness and cost-effectiveness: The case of tumour necrosis factor-alpha antagonist for ankylosing spondylitis in the dutch society
Citation
FRI0405 Simultaneously forecasting burden of illness and cost-effectiveness: The case of tumour necrosis factor-alpha antagonist for ankylosing spondylitis in the dutch society
Publication history
- First published January 23, 2014.
Online issue publication
January 23, 2014
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions